{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:12:19Z","timestamp":1791655939558,"version":"4.3.4"},"reference-count":24,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Alpha-1 antitrypsin deficiency (AATD) is a rare genetic condition associated with chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD) and emphysema, and with liver involvement through a distinct toxic gain-of-function mechanism. Despite its clinical relevance, AATD remains underdiagnosed and exhibits marked phenotypic heterogeneity. Artificial intelligence (AI) has shown growing potential in respiratory medicine, yet its application to AATD is still limited. This systematic review synthesizes the clinical evidence on AI in AATD, primarily in the respiratory domain and, where available, in hepatic outcomes. Materials and Methods: We conducted a PRISMA-guided search (PubMed, Web of Science, IEEE Xplore) for original, peer-reviewed articles (January 2014\u2013September 2025) applying AI to detection, classification, stratification, or prediction tasks in AATD. Results: Six studies met eligibility criteria. Supervised models (e.g., XGBoost, penalized regression, Transformer-based architectures) and one unsupervised approach were identified. Applications included screening in COPD populations, prediction of emphysema progression from CT, proteomic modeling of lung function, identification of clinical subgroups, and prediction of clinical outcomes in AATD-associated liver disease. External validation and genotype diversity remained limited across studies. Conclusions: Although AI shows promise in improving detection, prognosis, and patient stratification in AATD across both respiratory and hepatic manifestations, the current evidence remains limited. Broader, multicenter validation in genotype-diverse cohorts is required to confirm its clinical utility and support the implementation of precision medicine in AATD.<\/jats:p>","DOI":"10.3390\/medicina61101768","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:54:48Z","timestamp":1759229688000},"page":"1768","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Applications of Artificial Intelligence in Alpha-1 Antitrypsin Deficiency: A Systematic Review from a Respiratory Medicine Perspective"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1494-8145","authenticated-orcid":false,"given":"Manuel","family":"Casal-Guisande","sequence":"first","affiliation":[{"name":"Fundaci\u00f3n P\u00fablica Galega de Investigaci\u00f3n Biom\u00e9dica Galicia Sur, Hospital \u00c1lvaro Cunqueiro, 36312 Vigo, Spain"},{"name":"NeumoVigo I+i Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, 36312 Vigo, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red, CIBERES ISCIII, 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2833-0824","authenticated-orcid":false,"given":"Laura","family":"Villar-Aguilar","sequence":"additional","affiliation":[{"name":"NeumoVigo I+i Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, 36312 Vigo, Spain"},{"name":"Pulmonary Department, Hospital \u00c1lvaro Cunqueiro, 36312 Vigo, Spain"},{"name":"School of Industrial Engineering, University of Vigo, 36310 Vigo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7407-5249","authenticated-orcid":false,"given":"Alberto","family":"Fern\u00e1ndez-Villar","sequence":"additional","affiliation":[{"name":"NeumoVigo I+i Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, 36312 Vigo, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red, CIBERES ISCIII, 28029 Madrid, Spain"},{"name":"Pulmonary Department, Hospital \u00c1lvaro Cunqueiro, 36312 Vigo, Spain"},{"name":"School of Industrial Engineering, University of Vigo, 36310 Vigo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmeralda","family":"Garc\u00eda-Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"NeumoVigo I+i Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, 36312 Vigo, Spain"},{"name":"Pulmonary Department, Hospital \u00c1lvaro Cunqueiro, 36312 Vigo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5152-8903","authenticated-orcid":false,"given":"Ana","family":"Casal","sequence":"additional","affiliation":[{"name":"NeumoVigo I+i Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, 36312 Vigo, Spain"},{"name":"Pulmonary Department, Hospital \u00c1lvaro Cunqueiro, 36312 Vigo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6710-3766","authenticated-orcid":false,"given":"Mar\u00eda","family":"Torres-Dur\u00e1n","sequence":"additional","affiliation":[{"name":"NeumoVigo I+i Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, 36312 Vigo, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red, CIBERES ISCIII, 28029 Madrid, Spain"},{"name":"Pulmonary Department, Hospital \u00c1lvaro Cunqueiro, 36312 Vigo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1700610","DOI":"10.1183\/13993003.00610-2017","article-title":"European Respiratory Society statement: Diagnosis and treatment of pulmonary disease in \u03b11-antitrypsin deficiency","volume":"50","author":"Miravitlles","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13023-018-0856-9","article-title":"Alpha-1 antitrypsin deficiency: Outstanding questions and future directions","volume":"13","author":"Barrecheguren","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1164\/rccm.168.7.818","article-title":"American Thoracic Society, European Respiratory Society. American Thoracic Society\/European Respiratory Society statement: Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency","volume":"168","author":"Stoller","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.bpg.2010.08.006","article-title":"Alpha-1-antitrypsin deficiency","volume":"24","author":"Bals","year":"2010","journal-title":"Best. Pract. Res. Clin. Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1157\/13095974","article-title":"Guidelines for the Diagnosis and Management of \u03b11-Antitrypsin Deficiency","volume":"42","author":"Vidal","year":"2006","journal-title":"Arch. Bronconeumol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.arbr.2011.06.004","article-title":"Factors Associated with the Evolution of Lung Function in Patients with Alpha-1 Antitrypsin Deficiency in the Spanish Registry","volume":"47","author":"Lara","year":"2011","journal-title":"Arch. Bronconeumol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"835","DOI":"10.2147\/COPD.S298585","article-title":"There is No Fast Track to Identify Fast Decliners in Alpha-1 Antitrypsin Deficiency by Spirometry: A Longitudinal Study of Repeated Measurements","volume":"16","author":"Stockley","year":"2021","journal-title":"Int. J. COPD"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1159\/000537759","article-title":"Predicting Exacerbations in Alpha-1 Antitrypsin Deficiency Using Clinical and Pulmonary Function Tests: Portuguese EARCO Registry","volume":"103","author":"Faria","year":"2024","journal-title":"Respiration"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1080\/17476348.2024.2302940","article-title":"Demystification of artificial intelligence for respiratory clinicians managing patients with obstructive lung diseases","volume":"17","author":"Marques","year":"2023","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e872","DOI":"10.1016\/S2589-7500(23)00177-2","article-title":"Machine learning and deep learning predictive models for long-term prognosis in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis","volume":"5","author":"Smith","year":"2023","journal-title":"Lancet Digit. Health"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Casal-Guisande, M., Mosteiro-A\u00f1\u00f3n, M., Torres-Dur\u00e1n, M., Comesa\u00f1a-Campos, A., and Fern\u00e1ndez-Villar, A. (2025). Application of Artificial Intelligence for the Detection of Obstructive Sleep Apnea based on Clinical and Demographic Data: A Systematic Review. Expert Rev. Respir. Med.","DOI":"10.1080\/17476348.2025.2567046"},{"key":"ref_12","first-page":"264","article-title":"Clinical and Social Characterization of Patients Hospitalized for COPD Exacerbation Using Machine Learning Tools","volume":"61","author":"Golpe","year":"2024","journal-title":"Arch. Bronconeumol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2201949","DOI":"10.1183\/13993003.01949-2022","article-title":"Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries: EARCO international registry","volume":"61","author":"Miravitlles","year":"2023","journal-title":"Eur. Respir. J."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.medcli.2010.01.015","article-title":"Declaraci\u00f3n PRISMA: Una propuesta para mejorar la publicaci\u00f3n de revisiones sistem\u00e1ticas y metaan\u00e1lisis","volume":"135","author":"Bonfill","year":"2010","journal-title":"Med. Clin."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12931-025-03320-8","article-title":"Assessing inflammatory protein biomarkers in COPD subjects with and without alpha-1 antitrypsin deficiency","volume":"26","author":"Moll","year":"2025","journal-title":"Respir. Res."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Curiale, A.H., and San Jos\u00e9 Est\u00e9par, R. (2025). Novel Lobe-based Transformer model (LobTe) to predict emphysema progression in Alpha-1 Antitrypsin Deficiency. Comput. Biol. Med., 185.","DOI":"10.1016\/j.compbiomed.2024.109500"},{"key":"ref_17","first-page":"1","article-title":"Improving the Likelihood of Identifying Alpha-1 Antitrypsin Deficiency Among Patients With COPD: A Novel Predictive Model Using Real-World Data","volume":"12","author":"Pfeffer","year":"2025","journal-title":"Chronic Obstr. Pulm. Dis. J. COPD Found."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Spittle, D.A., Mansfield, A., Pye, A., Turner, A.M., and Newnham, M. (2023). Predicting Lung Function Using Biomarkers in Alpha-1 Antitrypsin Deficiency. Biomedicines, 11.","DOI":"10.3390\/biomedicines11072001"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"108278","DOI":"10.1016\/j.rmed.2025.108278","article-title":"Characterisation of patients with Alpha-1 antitrypsin deficiency using unsupervised machine learning tools","volume":"247","author":"Miravitlles","year":"2025","journal-title":"Respir. Med."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Meng, L., Treem, W., Heap, G.A., and Chen, J. (2022). A stacking ensemble machine learning model to predict alpha-1 antitrypsin deficiency-associated liver disease clinical outcomes based on UK Biobank data. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-21389-9"},{"key":"ref_21","first-page":"668","article-title":"The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the Adult","volume":"3","author":"Sandhaus","year":"2016","journal-title":"Chronic Obstr. Pulm. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1164\/ajrccm\/140.4.961","article-title":"Alpha-1-Antitrypsin Deficiency: High Prevalence in the St. Louis Area Determined by Direct Population Screening","volume":"140","author":"Silverman","year":"1989","journal-title":"Am. Rev. Respir. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"S317","DOI":"10.1513\/AnnalsATS.201506-349KV","article-title":"Detecting Alpha-1 Antitrypsin Deficiency: Current State, Impediments, Opportunities, and Future Directions","volume":"13","author":"Stoller","year":"2024","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_24","unstructured":"Kelleher, J.D., Mac Namee, B., and D\u2019Arcy, A. (2020). Fundamentals of Machine Learning for Predictive Data Analytics, The MIT Press."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/10\/1768\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:47:52Z","timestamp":1759236472000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/10\/1768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":24,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["medicina61101768"],"URL":"https:\/\/doi.org\/10.3390\/medicina61101768","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]}}}